Skip to main content
CG Invites Co., Ltd. logo

CG Invites Co., Ltd. — Investor Relations & Filings

Ticker · 083790 ISIN · KR7083790006 KO Manufacturing
Open in API
Filings indexed 450 across all filing types
Latest filing 2022-12-21 Regulatory Filings
Country KR South Korea
Listing KO 083790

About CG Invites Co., Ltd.

https://cginvites.com/en

CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.

Recent filings

Filing Released Lang Actions
[기재정정]신규시설투자등
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from CrystalGenomics regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to the investment period and board resolution date for a construction project. Since this is a specific regulatory announcement regarding corporate capital expenditure and investment updates that does not fit into the other specialized categories like M&A or Share Issues, it falls under the general regulatory filing category.
2022-12-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the administrative procedure for shareholder identification. Given its nature as a regulatory notification regarding meeting preparation, it fits best under the RNS category.
2022-12-16 Korean
[기재정정]분기보고서 (2022.09)
Interim / Quarterly Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a Quarterly Report (분기보고서) filed by CrystalGenomics Inc. It explicitly details corrections made to financial statements, research and development expenses, and cash flow tables that were originally submitted in a previous filing. Since it contains substantive financial data and is a formal correction to an interim financial report, it is classified as an Interim/Quarterly Report. 9M 2022
2022-12-09 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an Investor Relations (IR) meeting (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an upcoming event rather than the presentation slides themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2022-11-29 Korean
주주총회소집결의(임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for CrystalGenomics, detailing the date, time, location, and agenda items (specifically, a proposal to amend the articles of incorporation). This type of document is a standard proxy solicitation or meeting notice sent to shareholders to inform them of an upcoming meeting and the matters to be voted upon. Given the specific category list, 'PSI' (Proxy Solicitation & Information Statement) is the most accurate classification for a notice of a shareholder meeting.
2022-11-29 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Extraordinary General Meeting (EGM). It does not contain the full proxy materials or the meeting results themselves, but rather serves as a formal regulatory notice of the procedural steps for the meeting. As it does not fit into specific categories like AGM-R or PSI, and is a standard regulatory disclosure, it is classified as a general regulatory filing.
2022-11-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.